Protolabs Reports Record Q1 2026 Revenue and Improved Profitability

Key Highlights from Q1 2026 Earnings Report

• Record Quarterly Revenue: Protolabs reported revenue of \$139.3 million for the first quarter of 2026, representing a 10.4% year-over-year increase.
• Strong Earnings Growth: GAAP earnings per share stood at \$0.33, while non-GAAP earnings per share reached \$0.55—the highest non-GAAP EPS in over five years.
• Profitability Improvements: Gross profit was \$63.6 million (GAAP gross margin of 45.6%), up from \$55.7 million and 44.1% margin in Q1 2025.
• Cash Position: Cash and investments totaled \$158.0 million as of March 31, 2026.
• Guidance: The company expects full-year 2026 revenue growth between 6% and 8%.
• Q2 2026 Outlook: GAAP diluted EPS guidance for Q2 is \$0.29 to \$0.37, with non-GAAP diluted EPS guidance of \$0.45 to \$0.55.

Detailed Financial Results

• Segment Revenue:
  • Injection Molding: \$51.1 million
  • CNC Machining: \$30.5 million
  • 3D Printing: \$16.1 million
  • Sheet Metal: \$3.1 million
  • Other Revenue: \$0.2 million
• Income and Margins:
  • Income from operations: \$9.8 million (up from \$4.5 million in Q1 2025)
  • GAAP operating margin: 7.1% (up from 3.6% in Q1 2025)
  • Non-GAAP operating margin: 11.0% (up from 7.4%)
  • EBITDA: \$18.1 million (EBITDA margin 13.0%)
  • Non-GAAP net income: \$13.1 million (vs \$8.1 million in Q1 2025)
• Cash Flow:
  • Strong operating cash flow, with net cash provided by operating activities at \$11.0 million in Q1 2026.
  • Investing activities used net cash of (\$4.8 million), primarily from purchases of marketable securities and property/equipment.
  • Share repurchases: No repurchases in Q1 2026 (compared to \$20.9 million in Q1 2025).
• Balance Sheet:
  • Total assets: \$1.07 billion
  • Shareholders’ equity: \$683.1 million

Management Commentary

“First quarter results reflect the strength of our operating model, delivering record revenue alongside improved profitability,” said Dan Schumacher, Chief Financial Officer. “We generated strong cash flow and reported our highest non-GAAP earnings per share in more than five years, while continuing to invest in our strategic pillars and transformational initiatives to support long-term profitable growth.”

Shareholder-Relevant and Price-Sensitive Information

• Record revenue and profit growth—especially the significant improvement in both GAAP and non-GAAP earnings—demonstrate sustained demand and effective cost management, potentially driving positive investor sentiment and share price appreciation.
• Raised full-year growth outlook and positive Q2 EPS guidance signal confidence in ongoing business momentum.
• Strong cash position enhances Protolabs’ ability to invest in growth and return capital to shareholders in the future.
• No share repurchases in Q1 2026 could indicate a shift in capital allocation or confidence in internal investment opportunities.
• Non-GAAP results (excluding restructuring, transformation costs, and stock-based compensation) are provided for transparency and may influence how investors evaluate the company’s core operating performance.

Forward Guidance and Outlook

• Q2 2026 GAAP diluted net income per share is expected to be in the range of \$0.29 to \$0.37.
• Non-GAAP diluted net income per share guidance is \$0.45 to \$0.55.
• Full-year 2026 revenue growth is projected at 6% to 8%.

This guidance provides a positive outlook and demonstrates management’s expectation of continued growth and profitability, which is likely to be viewed favorably by investors.

Non-GAAP Metrics Disclosure

Protolabs notes that non-GAAP financial measures—such as adjusted EBITDA, non-GAAP net income, and non-GAAP gross and operating margins—exclude stock-based compensation, restructuring and transformation costs, and other items to provide a clearer view of underlying business performance.

Potential Share Price Drivers

• Record-setting top-line and bottom-line results, with the highest non-GAAP EPS in over five years.
• Strong financial position with significant cash reserves.
• Positive management commentary and improved forward guidance.
• Expansion in profitability metrics, such as gross margin and operating margin, indicating operational leverage.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all financial filings and consult their own advisors before making any investment decisions. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

View Proto Labs Inc Historical chart here